Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development

Por um escritor misterioso

Descrição

Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Cipargamin - an overview
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. - Abstract - Europe PMC
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Compounds 1a-c and 2a-b bind in the Plasmodium NMT peptide binding
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
The NMT recognition site is characterized by four distinct pockets, a
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Frontiers Comparative Metabolic Pathways Analysis and Subtractive Genomics Profiling to Prioritize Potential Drug Targets Against Streptococcus pneumoniae
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Structure of the N-terminal region of ScNMT. A, molecular surface of
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
ACS Infectious Diseases
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. - Abstract - Europe PMC
de por adulto (o preço varia de acordo com o tamanho do grupo)